Improving the human papillomavirus vaccination in the Philippines.
作者信息
Cordero Dalmacito A
机构信息
Department of Theology and Religious Education, De La Salle University, 2401 Taft Avenue, Manila 1004, Philippines.
出版信息
Ther Adv Vaccines Immunother. 2025 Mar 17;13:25151355251326783. doi: 10.1177/25151355251326783. eCollection 2025.
Abstract
摘要
相似文献
1
Improving the human papillomavirus vaccination in the Philippines.改善菲律宾的人乳头瘤病毒疫苗接种情况。
Ther Adv Vaccines Immunother. 2025 Mar 17;13:25151355251326783. doi: 10.1177/25151355251326783. eCollection 2025.
2
Cost-effectiveness analysis of AS04-adjuvanted human papillomavirus 16/18 vaccine compared with human papillomavirus 6/11/16/18 vaccine in the Philippines, with the new 2-dose schedule.在菲律宾采用新的两剂次接种程序时，AS04佐剂人乳头瘤病毒16/18型疫苗与人乳头瘤病毒6/11/16/18型疫苗的成本效益分析
Hum Vaccin Immunother. 2017 May 4;13(5):1158-1166. doi: 10.1080/21645515.2016.1269991. Epub 2017 Jan 11.
3
The cost-effectiveness of human papillomavirus vaccination in the Philippines.菲律宾人乳头瘤病毒疫苗接种的成本效益。
Vaccine. 2022 Jun 15;40(27):3802-3811. doi: 10.1016/j.vaccine.2022.05.025. Epub 2022 May 20.
4
A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines.菲律宾宫颈癌筛查与人乳头瘤病毒疫苗接种的成本效用分析
BMC Public Health. 2015 Jul 30;15:730. doi: 10.1186/s12889-015-2046-1.
5
Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.印度尼西亚、马来西亚、菲律宾、泰国和越南宫颈癌的流行病学与预防
Vaccine. 2008 Aug 19;26 Suppl 12:M71-9. doi: 10.1016/j.vaccine.2008.05.039.
6
Current Status of Human Papillomavirus Infection and Cervical Cancer in the Philippines.菲律宾人乳头瘤病毒感染与宫颈癌的现状
Front Med (Lausanne). 2022 Jun 20;9:929062. doi: 10.3389/fmed.2022.929062. eCollection 2022.
7
Integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the Asia-Pacific region.亚太地区部分国家和地区免疫规划中 HPV 疫苗接种建议的综合文献回顾。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2362449. doi: 10.1080/21645515.2024.2362449. Epub 2024 Jun 26.
8
The cost of human papillomavirus vaccination delivery at the administrative and health facility levels in the Philippines.菲律宾行政和医疗机构层面的人乳头瘤病毒疫苗接种成本。
Vaccine X. 2024 Feb 18;17:100459. doi: 10.1016/j.jvacx.2024.100459. eCollection 2024 Mar.
9
Incorporating economies of scale in the cost estimation in economic evaluation of PCV and HPV vaccination programmes in the Philippines: a game changer?在菲律宾肺炎球菌结合疫苗（PCV）和人乳头瘤病毒（HPV）疫苗接种计划的经济评估中，将规模经济纳入成本估算：这会是一个改变局面的因素吗？
Cost Eff Resour Alloc. 2018 Feb 20;16:7. doi: 10.1186/s12962-018-0087-x. eCollection 2018.
10
A multimodal approach to improving human papillomavirus vaccination in a community pharmacy setting.一种在社区药房环境中改善人乳头瘤病毒疫苗接种的多模式方法。
SAGE Open Med. 2016 Dec 14;4:2050312116682128. doi: 10.1177/2050312116682128. eCollection 2016.
本文引用的文献
1
Acceptability of human papillomavirus vaccination in the United Kingdom: a systematic review of the literature on uptake of, and barriers and facilitators to HPV vaccination.人乳头瘤病毒疫苗在英国的可接受性：关于人乳头瘤病毒疫苗接种率、障碍及促进因素的文献系统综述
Ther Adv Vaccines Immunother. 2024 Dec 25;12:25151355241308313. doi: 10.1177/25151355241308313. eCollection 2024.
2
Committee Opinion No. 704: Human Papillomavirus Vaccination.委员会意见 704：人乳头瘤病毒疫苗接种。
Obstet Gynecol. 2017 Jun;129(6):1. doi: 10.1097/AOG.0000000000002052.
3
HPV vaccine acceptability among women in the Philippines.菲律宾女性对人乳头瘤病毒（HPV）疫苗的接受度。
Asian Pac J Cancer Prev. 2010;11(6):1781-7.
Zotero 插件